APONVIE Trademark

Trademark Overview


On Monday, October 3, 2022, a trademark application was filed for APONVIE with the United States Patent and Trademark Office. The USPTO has given the APONVIE trademark a serial number of 97617077. The federal status of this trademark filing is REGISTERED as of Tuesday, November 14, 2023. This trademark is owned by Heron Therapeutics, Inc.. The APONVIE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
aponvie

General Information


Serial Number97617077
Word MarkAPONVIE
Filing DateMonday, October 3, 2022
Status700 - REGISTERED
Status DateTuesday, November 14, 2023
Registration Number7217342
Registration DateTuesday, November 14, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Description of MarkThe mark consists of the word "APONVIE" in stylized lettering.
Goods and ServicesAnti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 19, 2022
Primary Code005
First Use Anywhere DateThursday, March 2, 2023
First Use In Commerce DateThursday, March 2, 2023

Trademark Owner History


Party NameHeron Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameHeron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameHeron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, March 9, 2023AMENDMENT TO USE PROCESSING COMPLETE
Thursday, October 6, 2022NEW APPLICATION ENTERED
Wednesday, October 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 8, 2023TEAS AMENDMENT OF USE RECEIVED
Thursday, March 9, 2023USE AMENDMENT FILED
Tuesday, July 18, 2023ASSIGNED TO EXAMINER
Tuesday, July 18, 2023USE AMENDMENT ACCEPTED
Wednesday, July 19, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sunday, July 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 14, 2023REGISTERED-PRINCIPAL REGISTER